Siemens Healthineers makes $300m investment in Massachusetts


Siemens Healthineers makes $300m investment in Massachusetts

Wallix / iStock

Siemens Healthineers, the healthcare business of Siemens AG, has made $300 million investment in Walpole, Massachusetts.

The company has announced its plans to further expand its manufacturing and R&D facility for laboratory diagnostics that is expected to create up to 700 new high-tech jobs over the next 10 years, according to the statement.

The move is a part of its broader strategy to create local value in the US, Siemens’ largest market.

"Healthcare is changing all over the world, and these changes are opening up great opportunities for providers, for patients—and for our company," said Michael Sen, member of the managing board of Siemens AG and Siemens Healthcare GmbH supervisory board chairman.

"Today, we provide more than 10 billion laboratory diagnostics tests each year. Our mission is to extend this reach even further and Walpole will play a major role in this effort. That’s why we’re investing 300 million dollars here—one of the largest single capital investments of Siemens Healthcare in the U.S. ever. We look forward to innovations from here—innovations that will benefit our customers, that will benefit Siemens and, most of all, that will benefit patients."

Lisa Davis, chair and CEO of Siemens Corporation and member of the managing board of Siemens AG, added: "Siemens has been doing business in the United States for more than 160 years. We not only deliver products and solutions to America, but the Walpole expansion demonstrates our passion for making things here, hiring here and working closely with US customers.

"By investing in advanced manufacturing right here in the US, Siemens creates value for customers and communities, produces high-wage jobs, increases exports and creates more orders for local businesses of all sizes."

As the global healthcare market transforms, healthcare providers continue to be under pressure to improve efficiencies to deliver better outcomes at lower costs.

Franz Walt, president, laboratory diagnostics, Siemens Healthineers, said: "Our investment in Walpole expands our global footprint and reflects our long history of innovations that help healthcare providers meet their current and future business challenges.”

"With this investment, we will expand our capabilities to deliver solutions such as our new Atellica portfolio of products to give lab professionals control and simplicity so they can spend less time on operations and more time driving better outcomes."

Siemens Healthineers, Walpole, Massachusetts, Healthcare, Technology, US